Incidence of hepatitis B and C in children with cancer: a single institution experience in Iraq
DOI:
https://doi.org/10.62480/tjms.2022.vol15.pp146-153Keywords:
Hepatitis B, hepatitis C, malignancy, childrenAbstract
Hepatitis viruses, including B and C, are present in a large number of cancer cases, such as leukemia, and they are responsible for most of hepatitis. Objective: To determine the incidence of hepatitis virus infection among children being treated for cancer and to evaluate the factors that may increase the risk of infection. Methods: A cross-sectional study was conducted at Al-Imam Al-Hussain Oncology Center in Kerbala during a period of seven months, from the 13th of June 2019 till the 13th of January 2020. One hundred fifty-one patients were included in this study; their ages were < 18 years. They were diagnosed with cancer for at least six months before. They were either on current treatment or finished treatment and were attending for follow-up. A two ml of blood was drawn from all patients to test for liver function test, hepatitis B surface antigen (HBs Ag), and anti-hepatitis C antibody (anti-HCV). Results: In this study, the incidence of hepatitis C was 4%, and the incidence of hepatitis B was 1.3%. The highest prevalence of hepatitis infection was significantly seen in patients who received platelets transfusion more than ten times, in leukemia patients, in patients who received packed RBC transfusion 1-10 times, in patients who had elevated liver function tests, and in patients who received the last transfusion outside Kerbala. Conclusion: Incidence of blood born hepatitis is comparable with other published studies, higher with more frequent blood product transfusion, and higher with hematological malignancies rather than solid malignancies
References
Hepatitis B Questions and Answers for the Public. Cdc.gov. 2020 [cited 7 January 2020]. Available from: https://www.cdc.gov/hepatitis/hbv/bfaq.htm#overview.
Al Sadeq DW, Majdalawieh AF, Nasrallah GK. Seroprevalence and incidence of hepatitis E virus among blood donors: A review. Reviews in medical virology. 2017 Sep;27 (5): e1937.
Hepatitis B. Who. int. 2020 [cited 7 January 2020]. Available from: https://www.who.int/en/news-room/fact-sheets/detail/hepatitis-b.
Shen T, Yan XM. Hepatitis B virus genetic mutations and evolution in liver diseases. World journal of gastroenterology: WJG. 2014 May 14;20 (18):5435.
Kose S, Olmezoglu A, Gozaydin A, Ece G. Seroprevalence of hepatitis B and C among oncology patients in Turkey. Journal of health, population, and nutrition. 2011 Dec;29 (6):652.
Gasim GI. Hepatitis B virus in the Arab world: Where do we stand? Arab Journal of Gastroenterology. 2013 Jun 1;14 (2):35-43.
Te HS, Jensen DM. Epidemiology of hepatitis B and C viruses: a global overview. Clinics in liver disease. 2010 Feb 1;14 (1):1-21.
Hepatitis B: Practice Essentials, Background, Pathophysiology. Emedicine.medscape.com. 2020[cited January 2020]. Available from: https://emedicine.medscape.com/article/177632-overview#a5.
Yan H, Zhong G, Xu G, He W, Jing Z, Gao Z, Huang Y, Qi Y, Peng B, Wang H, Fu L. Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus. elife. 2012 Nov 13;1: e00049.
Ni Y, Lempp FA, Mehrle S, Nkongolo S, Königer C, Nassal M, Kubitz R, Sültmann H. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes. Gastroenterology. 2014 Apr 1;146 (4):1070-83.
Hepatitis B Questions and Answers for the Public | CDC. Cdc.gov. 2020 [cited 15 February 2020]. Available from: https://www.cdc.gov/hepatitis/hbv/bfaq.htm
Hepatitis B - Symptoms and causes. Mayo Clinic. 2020 [cited 8 January 2020]. Available from:https://www.mayoclinic.org/diseases-conditions/hepatitis-b/symptoms-causes/syc-20366802.
Oakes K. Hepatitis B: prevalence and pathophysiology. Nursing times. 2014;110 (7):12-6.
You CR, Lee SW, Jang JW, Yoon SK. Update on hepatitis B virus infection. World journal of gastroenterology: WJG. 2014 Oct 7;20 (37):13293
Hepatitis B: Risk Factors, Symptoms, and Diagnosis. Health line. 2020 [cited 8 January 2020]. Available from: https://www.healthline.com/health/hepatitis-b#risk-factors.
Liaw YF, Brunetto MR, Hadziyannis S. The natural history of chronic HBV infection and geographical differences. Antiviral therapy. 2010 Jan 1;15 (3):25.
Mahy BW, Van Regenmortel MH, editors. Desk encyclopedia of human and medical virology. Academic Press; 2010 May 21.
Hepatitis B: Causes, symptoms, and treatment. Medical News Today. 2020 [cited 8 January 2020]. Available from:https://www.medicalnewstoday.com/articles/306288.php#causes.
Moosavy SH, Davoodian P, Nazarnezhad MA, Nejatizaheh A, Eftekhar E, Mahboobi H. Epidemiology, transmission, diagnosis, and outcome of Hepatitis C virus infection. Electronic physician. 2017 Oct; 9 (10):5646.
Hepatitis C. Who? int. 2020 [cited 9 January 2020]. Available from: https://www.who.int/news-room/fact-sheets/detail/hepatitis-c.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
User Rights
Under the Creative Commons Attribution-NonCommercial 4.0 International (CC-BY-NC), the author (s) and users are free to share (copy, distribute and transmit the contribution).
Rights of Authors
Authors retain the following rights:
1. Copyright and other proprietary rights relating to the article, such as patent rights,
2. the right to use the substance of the article in future works, including lectures and books,
3. the right to reproduce the article for own purposes, provided the copies are not offered for sale,
4. the right to self-archive the article.
